rs17403955

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001142800.2(EYS):​c.4081A>G​(p.Ile1361Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.129 in 1,550,880 control chromosomes in the GnomAD database, including 13,838 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I1361M) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.10 ( 927 hom., cov: 33)
Exomes 𝑓: 0.13 ( 12911 hom. )

Consequence

EYS
NM_001142800.2 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.164

Publications

13 publications found
Variant links:
Genes affected
EYS (HGNC:21555): (eyes shut homolog) The product of this gene contains multiple epidermal growth factor (EGF)-like and LamG domains. The protein is expressed in the photoreceptor layer of the retina, and the gene is mutated in autosomal recessive retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
EYS Gene-Disease associations (from GenCC):
  • EYS-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • retinitis pigmentosa 25
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0018867254).
BP6
Variant 6-64591786-T-C is Benign according to our data. Variant chr6-64591786-T-C is described in ClinVar as Benign. ClinVar VariationId is 93610.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.157 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EYSNM_001142800.2 linkc.4081A>G p.Ile1361Val missense_variant Exon 26 of 43 ENST00000503581.6 NP_001136272.1 Q5T1H1-1
EYSNM_001292009.2 linkc.4081A>G p.Ile1361Val missense_variant Exon 26 of 44 NP_001278938.1 Q5T1H1-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EYSENST00000503581.6 linkc.4081A>G p.Ile1361Val missense_variant Exon 26 of 43 5 NM_001142800.2 ENSP00000424243.1 Q5T1H1-1
EYSENST00000370621.7 linkc.4081A>G p.Ile1361Val missense_variant Exon 26 of 44 1 ENSP00000359655.3 Q5T1H1-3

Frequencies

GnomAD3 genomes
AF:
0.101
AC:
15354
AN:
152008
Hom.:
930
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0365
Gnomad AMI
AF:
0.105
Gnomad AMR
AF:
0.124
Gnomad ASJ
AF:
0.0720
Gnomad EAS
AF:
0.167
Gnomad SAS
AF:
0.112
Gnomad FIN
AF:
0.0739
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.135
Gnomad OTH
AF:
0.0986
GnomAD2 exomes
AF:
0.119
AC:
18240
AN:
153680
AF XY:
0.119
show subpopulations
Gnomad AFR exome
AF:
0.0306
Gnomad AMR exome
AF:
0.136
Gnomad ASJ exome
AF:
0.0820
Gnomad EAS exome
AF:
0.175
Gnomad FIN exome
AF:
0.0820
Gnomad NFE exome
AF:
0.133
Gnomad OTH exome
AF:
0.118
GnomAD4 exome
AF:
0.132
AC:
185083
AN:
1398754
Hom.:
12911
Cov.:
35
AF XY:
0.132
AC XY:
91038
AN XY:
689902
show subpopulations
African (AFR)
AF:
0.0303
AC:
958
AN:
31578
American (AMR)
AF:
0.135
AC:
4819
AN:
35686
Ashkenazi Jewish (ASJ)
AF:
0.0797
AC:
2004
AN:
25160
East Asian (EAS)
AF:
0.145
AC:
5170
AN:
35732
South Asian (SAS)
AF:
0.105
AC:
8279
AN:
79200
European-Finnish (FIN)
AF:
0.0808
AC:
3981
AN:
49270
Middle Eastern (MID)
AF:
0.0573
AC:
326
AN:
5692
European-Non Finnish (NFE)
AF:
0.141
AC:
152344
AN:
1078460
Other (OTH)
AF:
0.124
AC:
7202
AN:
57976
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
8846
17692
26537
35383
44229
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5580
11160
16740
22320
27900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.101
AC:
15349
AN:
152126
Hom.:
927
Cov.:
33
AF XY:
0.0993
AC XY:
7392
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.0364
AC:
1513
AN:
41532
American (AMR)
AF:
0.124
AC:
1896
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.0720
AC:
250
AN:
3470
East Asian (EAS)
AF:
0.166
AC:
856
AN:
5156
South Asian (SAS)
AF:
0.112
AC:
542
AN:
4824
European-Finnish (FIN)
AF:
0.0739
AC:
784
AN:
10608
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.135
AC:
9186
AN:
67962
Other (OTH)
AF:
0.0975
AC:
206
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
723
1447
2170
2894
3617
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
174
348
522
696
870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.122
Hom.:
2574
Bravo
AF:
0.105
TwinsUK
AF:
0.135
AC:
501
ALSPAC
AF:
0.128
AC:
494
ESP6500AA
AF:
0.0354
AC:
49
ESP6500EA
AF:
0.140
AC:
446
ExAC
AF:
0.0954
AC:
2106
Asia WGS
AF:
0.122
AC:
422
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Sep 19, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 11, 2011
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Retinitis pigmentosa Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Retinitis pigmentosa 25 Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinal dystrophy Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
6.2
DANN
Benign
0.76
DEOGEN2
Benign
0.042
.;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.068
N
LIST_S2
Benign
0.42
T;T
MetaRNN
Benign
0.0019
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.34
N;N
PhyloP100
0.16
PrimateAI
Benign
0.23
T
PROVEAN
Benign
0.070
N;N
REVEL
Benign
0.078
Sift
Benign
0.54
T;T
Sift4G
Benign
0.57
T;T
Polyphen
0.0010
B;B
Vest4
0.021
MPC
0.010
ClinPred
0.00052
T
GERP RS
-1.2
Varity_R
0.031
gMVP
0.022
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17403955; hg19: chr6-65301679; COSMIC: COSV58205613; COSMIC: COSV58205613; API